These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 10569694

  • 41. The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives.
    Krettli AU.
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():142-51. PubMed ID: 19753469
    [Abstract] [Full Text] [Related]

  • 42. Complete immunization against Trypanosoma cruzi verified in individual mice by complement-mediated lysis.
    Gómez LE, Nasser JR, Basombrío MA.
    Mem Inst Oswaldo Cruz; 1996 Jul; 91(1):55-61. PubMed ID: 8734949
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Effect of protective and non-protective antibodies in the phagocytosis rate of Trypanosoma cruzi blood forms by mouse peritoneal macrophages.
    Lages-Silva E, Ramirez LE, Krettli AU, Brener Z.
    Parasite Immunol; 1987 Jan; 9(1):21-30. PubMed ID: 3104865
    [Abstract] [Full Text] [Related]

  • 49. Specificity and role of anti-Trypanosoma cruzi clearance antibodies.
    Umekita LF, Barbaro KC, Mota I.
    Braz J Med Biol Res; 1996 Jan; 29(1):25-31. PubMed ID: 8731328
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Vaccination with Trypanosoma rangeli modulates the profiles of immunoglobulins and IL-6 at local and systemic levels in the early phase of Trypanosoma cruzi experimental infection.
    Marini V, Moretti E, Bermejo D, Basso B.
    Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):32-7. PubMed ID: 21340352
    [Abstract] [Full Text] [Related]

  • 53. Anti-Trypanosoma cruzi and anti-laminin antibodies in chagasic patients after specific treatment.
    Gazzinelli RT, Galvão LM, Cardoso JE, Cançado JR, Krettli AU, Brener Z, Gazzinelli G.
    J Clin Microbiol; 1988 Sep; 26(9):1795-800. PubMed ID: 3141467
    [Abstract] [Full Text] [Related]

  • 54. Antibody-independent, natural resistance of birds to Trypanosoma cruzi infection.
    Kierszenbaum F, Gottlieb CA, Budzko DB.
    J Parasitol; 1981 Oct; 67(5):656-60. PubMed ID: 6795329
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Human chagasic serum contains antibodies capable of inhibiting Trypanosoma cruzi egress from tissue culture cells.
    Costales J, Rowland EC.
    J Parasitol; 2005 Aug; 91(4):950-3. PubMed ID: 17089772
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.